James Hamilton
Corporate Officer/Principal bij ARROWHEAD PHARMACEUTICALS, INC.
Vermogen: 6 M $ op 31-03-2024
Profiel
James C.
Hamilton is the founder of NanoValent Pharmaceuticals, Inc. (founded in 2005).
He is currently the Chief Discovery & Translational Medicine at Arrowhead Pharmaceuticals, Inc. He was formerly the Chief Executive Officer at Calando Pharmaceuticals, Inc. Dr. Hamilton received his undergraduate degree from Miami University and his MBA and doctorate degrees from The Ohio State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-04-2024 | 204 851 ( 0.17% ) | 6 M $ | 31-03-2024 |
Actieve functies van James Hamilton
| Bedrijven | Functie | Begin |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| NanoValent Pharmaceuticals, Inc. | Founder | 23-02-2010 |
Eerdere bekende functies van James Hamilton
| Bedrijven | Functie | Einde |
|---|---|---|
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | President | - |
Opleiding van James Hamilton
| Miami University | Undergraduate Degree |
| The Ohio State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
| NanoValent Pharmaceuticals, Inc. |
